Spermosens AB

📍 Lund, Sweden🗓 Founded 2018👥 10 employees💰 Last funded Nov 2018
Medical Equipment Manufacturing🌐 spermosens.com
Website LinkedIn
Spermosens goal is to improve male fertility diagnostics and treatment through the introduction of ground breaking products. Spermosens first patented product JUNO-Checked measures the binding capacity between sperm and egg cell, which is a prerequisite for natural fertilization. The results are deemed to be able to help doctors choose the appropriate treatment method, which contributes to more successful IVF treatments, reduced suffering, and increased quality of life. The WHO estimates that more than 48 million couples are affected by infertility, half of which is caused in whole or in part by a male factor. The companys shares are listed on Spotlight Stock market. The shares have ISIN code SE0015346424 and are traded under the short name SPERM. For more information, see www.spermosens.com
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
2
Frequently asked questions
Who invested in Spermosens AB?
Spermosens AB has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Spermosens AB last raise funding?
The most recent investment in Spermosens AB recorded on gritt.io was in November 2018.
When was Spermosens AB founded?
Spermosens AB was founded in 2018.
What industry is Spermosens AB in?
Spermosens AB operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Spermosens AB based?
Spermosens AB is headquartered in Lund, Sweden.